Aurobindo Pharma Limited
AUROPHARMA
Classifica tra le azioni
#2019
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Prezzo delle azioni
$17.89
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$10.30B
Variazione (1 giorno)
-2.27%
Variazione (1 anno)
43.03%
Paese
IN
Scambia Aurobindo Pharma Limited (AUROPHARMA)
Categoria
Healthcare
EPS per Aurobindo Pharma Limited (AUROPHARMA)
EPS al June 2026 TTM: $0.71
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Aurobindo Pharma Limited, l’EPS attuale della società (TTM) è $0.71. Alla fine del 2024, la società aveva un EPS di $0.65 un aumento rispetto a rispetto a quello del 2023, che era di $0.40.
Storico EPS per Aurobindo Pharma Limited da 2004 a 2026
EPS alla fine di ogni anno
| Anno | EPS | Cambia |
|---|---|---|
| 2026 (TTM) | $0.71 | 0.90% |
| 2025 | $0.70 | 7.68% |
| 2024 | $0.65 | 62.23% |
| 2023 | $0.40 | -32.77% |
| 2022 | $0.60 | -52.13% |
| 2021 | $1.24 | 92.96% |
| 2020 | $0.64 | 10.91% |
| 2019 | $0.58 | -8.50% |
| 2018 | $0.64 | 4.73% |
| 2017 | $0.61 | 15.90% |
| 2016 | $0.52 | 20.94% |
| 2015 | $0.43 | -3.95% |
| 2014 | $0.45 | 384.93% |
| 2013 | $0.09 | -322.25% |
| 2012 | $-0.04 | -119.03% |
| 2011 | $0.22 | -5.22% |
| 2010 | $0.23 | 529.89% |
| 2009 | $0.04 | -66.91% |
| 2008 | $0.11 | 27.82% |
| 2007 | $0.09 | 190.97% |
| 2006 | $0.03 | 1,893.33% |
| 2005 | 0.00 | -97.13% |
| 2004 | $0.05 | 0.00% |
EPS per aziende simili o concorrenti
| Azienda | EPS | Differenza di EPS | Il paese |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -21.24% |
IN
|
